Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia

IsraelCompletedPHASE1

Conditions

Chronic Myeloid Leukemia · Acute Lymphocytic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States
  • Charite University of Medicine, Berlin, Germany
  • Johann Wolfgang Goethe Universität, Frankfurt am Main, Germany
  • University of Heidelberg Medical Clinic, Mannheim, Germany
  • Chaim Sheba Medical Center, Tel Litwinsky, Israel